Our board moves wrap includes Benjamin Donovan, Graeme Morissey, Simon Robertson, John Traicos, Anson Heng, Chris Ntoumenopoulos, Paul Rennie, Tony Keating, and Stephen Quantrill.
Shares in Clough family-backed NeuroScientific Biopharmaceuticals have plunged after a planned clinical trial for its budding Alzheimer's treatment was rejected by the Human Research Ethics Committee.
Nedlands-based NeuroScientific Biopharmaceuticals, which has been bankrolled by the Clough family, is set to begin trading on the ASX tomorrow, after raising $6 million via an initial public offering.
